Viewing Study NCT05602766


Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2026-02-01 @ 7:06 PM
Study NCT ID: NCT05602766
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-02
First Post: 2022-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ngenla Subcutaneous Injection Special Investigation
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Growth Hormone Deficiency Without Epiphyseal Closure View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Growth hormone deficiency (GHD) View
None Recombinant human growth hormone (hGH) View
None once-weekly injection View
None Somatrogon View